GREGORY GILBREATH: Open Payments
NPI 1265485486 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 26 payments from 12 companies in 2025. Trend: 2023 $818 · 2024 $351 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $135 |
| Actelion Pharmaceuticals US, Inc. | 4 | $122 |
| Inspire Medical Systems, Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $67 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Innovation Technologies Inc | 1 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $17 |
Products named: VERQUVO, OPSUMIT, INSPIRE, CAMZYOS, OPSYNVI, LEQVIO, IRRISEPT, WINREVAIR.
Industry payments across TX — which companies pay providers there.
